Abstracts

1053 – HIV Viral Load Patterns Since Dolutegravir Initiation in Children and Adolescents Living With HIV

Background We modelled patterns of virological response to Dolutagravir (DTG)-based ART in a cohort of children and adolescents living with HIV in West Africa. Methods All CALHIV aged 0 to 19 years initiating DTG-based ART between 2019-2023 and enrolled in the West African pediatric International epidemiological Database for Evaluating AIDS (IeDEA pWADA) were included and followed…

1067 – Long-Term Immune Response to Vaccines in Vertically Infected People Living With HIV

Background Despite successful antiretroviral therapy (ART), people living with HIV (PLHIV) are at risk of suboptimal vaccine response, exposing this vulnerable population to common vaccine-preventable diseases.  Methods This cross-sectional observational study evaluated humoral responses to vaccination in a cohort of PLHIV with vertically acquired infection. Seroprotection rates for diphtheria, tetanus, measles, mumps, rubella, varicella, and…

1051 – Hospitalization Incidence Among Young Children Living With HIV in the Western Cape, South Africa

Background Studies of hospitalization among young children with HIV in resource-limited settings, in the context of early infant diagnosis and antiretroviral therapy (ART), are limited. Methods We used routinely collected data to describe hospitalization patterns among children diagnosed with HIV (born 2018-2022), in the Western Cape, South Africa. We used logistic regression to examine factors…

1111 – Temporal Variations of Racial Disparities in HIV Incidence in the United States From 2008 to 2021

Background Despite ongoing efforts to address racial disparities in HIV incidence, the Black/African American and Hispanic/Latino populations continue to be disproportionately affected by new HIV diagnoses. The current study aimed to explore the temporal trend of racial disparities in HIV incidence at the county level across the United States from 2008 to 2021, and to…

1033 – Proviral HIV-1 DNA Below Detection in Early-Treated Adolescents After Prior Treatment Interruption

Background Undetectable or low HIV-1 DNA levels have been associated with a greater likelihood of ART-free viral control in adults treated during primary infection. Here we investigate predictors of HIV-1 DNA levels in a cohort of early-treated children and adolescents recruited on characteristics expected to make them good candidates for future remission/cure trials.  Methods Parents…

942 – Immune Profile of Children With Post-COVID-19 Cardiac Contractility Alterations: A Prospective Study

Background Myocardial injuries have been observed after COVID-19 in previously healthy children, regardless of COVID-19 severity. Immune dysregulation may play a role in post-COVID cardiac alterations but remains unexplored in children. This study evaluated the immune response in children with or without asymptomatic cardiac contractility alterations after mild SARS-CoV-2 infection. Methods A prospective, observational study…

1023 – Cardiometabolic Outcomes in HEU vs HU Children in a SA Birth Cohort: Influence of Maternal Lipids

Background HIV-Exposed Uninfected (HEU) children have worse cardiometabolic health outcomes, compared to HIV-Unexposed uninfected (HU) children, but the effect of maternal cardiometabolic health in pregnancy on child outcomes is not clear. Our study investigated the impact of maternal gestational lipid biomarkers on child cardiometabolic health indicators in a birth cohort of South African HEU and…

1022 – Insulin-Like Growth Factors and Stunting in African Infants Exposed to HIV and Uninfected

Background The biological mechanisms related to increased risk of stunting in infants/children who are HIV-exposed and uninfected (CHEU) are not fully clear. We assessed whether insulin-like growth factors (IGFs), which are associated with infant growth, are determinants for stunting observed among CHEU. Methods A random sample of 213 out of 268 infants from the antepartum part of the IMPAACT P1084s…